Class information for:
Level 1: BASILIXIMAB//THYMOGLOBULIN//DACLIZUMAB

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
8195 1281 27.2 81%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
8 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1276458
98 3       TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//SURGERY 75394
93 2             TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//KIDNEY TRANSPLANTATION 26351
8195 1                   BASILIXIMAB//THYMOGLOBULIN//DACLIZUMAB 1281

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 BASILIXIMAB authKW 853900 6% 48% 75
2 THYMOGLOBULIN authKW 572179 4% 44% 55
3 DACLIZUMAB authKW 367763 4% 31% 50
4 ALEMTUZUMAB authKW 290752 7% 14% 85
5 CAMPATH 1H authKW 249068 3% 29% 36
6 RABBIT ANTITHYMOCYTE GLOBULIN authKW 191192 1% 42% 19
7 INDUCTION THERAPY authKW 191162 4% 15% 52
8 ANTITHYMOCYTE GLOBULIN authKW 162148 3% 17% 41
9 TRANSPLANTATION WoSSC 152064 71% 1% 912
10 ANTI THYMOCYTE GLOBULIN authKW 120394 2% 21% 24

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Transplantation 152064 71% 1% 912
2 Surgery 18940 64% 0% 821
3 Immunology 16941 55% 0% 701
4 Urology & Nephrology 855 8% 0% 105
5 Respiratory System 112 3% 0% 39
6 Cardiac & Cardiovascular System 72 4% 0% 55
7 Hematology 41 3% 0% 33
8 Pediatrics 39 3% 0% 38
9 Medicine, General & Internal 20 4% 0% 47
10 Pharmacology & Pharmacy 11 5% 0% 59

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 KLIN ALLGEMEIN VISZERAL TRANSPLANTAT MED 47671 0% 100% 2
2 TRANSPLANTAT 36024 7% 2% 96
3 PHARMACOECON TRANSPLANT 31779 0% 67% 2
4 SERV NEPHROL HTA DIALYSE TRANSPLANTAT 31779 0% 67% 2
5 A UCL NEPHROL 23835 0% 100% 1
6 ABT MED STAT INFORMAT GESUNDHEITSOKONOMIE 23835 0% 100% 1
7 AFFILIATED UROL NEPHROL HOSP 23835 0% 100% 1
8 AZIENDA OSPED P A GIOVANNI 23OSPED RIUNITI 23835 0% 100% 1
9 BARNES JEWISH HOSPRENAL 23835 0% 100% 1
10 CARDIOL MED VASC TECNOL MONTERREY 23835 0% 100% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 TRANSPLANTATION PROCEEDINGS 94942 31% 1% 398
2 TRANSPLANTATION 51919 16% 1% 200
3 CLINICAL TRANSPLANTATION 17307 4% 1% 52
4 TRANSPLANT INTERNATIONAL 17092 4% 2% 47
5 TRANSPLANT IMMUNOLOGY 14133 2% 2% 26
6 AMERICAN JOURNAL OF TRANSPLANTATION 11511 4% 1% 48
7 PEDIATRIC TRANSPLANTATION 7544 2% 1% 27
8 ANNALS OF TRANSPLANTATION 5577 1% 2% 13
9 JOURNAL OF HEART AND LUNG TRANSPLANTATION 5410 3% 1% 33
10 JOURNAL OF HEART TRANSPLANTATION 3301 0% 2% 6

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 BASILIXIMAB 853900 6% 48% 75 Search BASILIXIMAB Search BASILIXIMAB
2 THYMOGLOBULIN 572179 4% 44% 55 Search THYMOGLOBULIN Search THYMOGLOBULIN
3 DACLIZUMAB 367763 4% 31% 50 Search DACLIZUMAB Search DACLIZUMAB
4 ALEMTUZUMAB 290752 7% 14% 85 Search ALEMTUZUMAB Search ALEMTUZUMAB
5 CAMPATH 1H 249068 3% 29% 36 Search CAMPATH+1H Search CAMPATH+1H
6 RABBIT ANTITHYMOCYTE GLOBULIN 191192 1% 42% 19 Search RABBIT+ANTITHYMOCYTE+GLOBULIN Search RABBIT+ANTITHYMOCYTE+GLOBULIN
7 INDUCTION THERAPY 191162 4% 15% 52 Search INDUCTION+THERAPY Search INDUCTION+THERAPY
8 ANTITHYMOCYTE GLOBULIN 162148 3% 17% 41 Search ANTITHYMOCYTE+GLOBULIN Search ANTITHYMOCYTE+GLOBULIN
9 ANTI THYMOCYTE GLOBULIN 120394 2% 21% 24 Search ANTI+THYMOCYTE+GLOBULIN Search ANTI+THYMOCYTE+GLOBULIN
10 ANTI IL 2 RECEPTOR 99313 0% 83% 5 Search ANTI+IL+2+RECEPTOR Search ANTI+IL+2+RECEPTOR

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 HARDINGER, KL , BRENNAN, DC , KLEIN, CL , (2013) SELECTION OF INDUCTION THERAPY IN KIDNEY TRANSPLANTATION.TRANSPLANT INTERNATIONAL. VOL. 26. ISSUE 7. P. 662 -672 68 81% 11
2 MCKEAGE, K , MCCORMACK, PL , (2010) BASIFIXIMAB A REVIEW OF ITS USE AS INDUCTION THERAPY IN RENAL TRANSPLANTATION.BIODRUGS. VOL. 24. ISSUE 1. P. 55-76 68 72% 19
3 WEBSTER, AC , RUSTER, LP , MCGEE, R , MATHESON, SL , HIGGINS, GY , WILLIS, NS , CHAPMAN, JR , CRAIG, JC , (2010) INTERLEUKIN 2 RECEPTOR ANTAGONISTS FOR KIDNEY TRANSPLANT RECIPIENTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 1. P. - 80 55% 39
4 MOURAD, G , MORELON, E , NOEL, C , GLOTZ, D , LEBRANCHU, Y , (2012) THE ROLE OF THYMOGLOBULIN INDUCTION IN KIDNEY TRANSPLANTATION: AN UPDATE.CLINICAL TRANSPLANTATION. VOL. 26. ISSUE 5. P. E450-E464 68 65% 14
5 BOWMAN, LJ , EDWARDS, A , BRENNAN, DC , (2014) THE ROLE OF RABBIT ANTITHYMOCYTE GLOBULIN IN RENAL TRANSPLANTATION.EXPERT OPINION ON ORPHAN DRUGS. VOL. 2. ISSUE 9. P. 971 -987 60 73% 0
6 MOHTY, M , BACIGALUPO, A , SALIBA, F , ZUCKERMANN, A , MORELON, E , LEBRANCHU, Y , (2014) NEW DIRECTIONS FOR RABBIT ANTITHYMOCYTE GLOBULIN (THYMOGLOBULIN (R)) IN SOLID ORGAN TRANSPLANTS, STEM CELL TRANSPLANTS AND AUTOIMMUNITY.DRUGS. VOL. 74. ISSUE 14. P. 1605 -1634 98 40% 9
7 THIYAGARAJAN, UM , PONNUSWAMY, A , BAGUL, A , (2013) THYMOGLOBULIN AND ITS USE IN RENAL TRANSPLANTATION: A REVIEW.AMERICAN JOURNAL OF NEPHROLOGY. VOL. 37. ISSUE 6. P. 586-601 61 61% 13
8 CHAPMAN, TM , KEATING, GM , (2003) BASIFIXIMAB - A REVIEW OF ITS USE AS INDUCTION THERAPY IN RENAL TRANSPLANTATION.DRUGS. VOL. 63. ISSUE 24. P. 2803-2835 48 79% 57
9 CIANCIO, G , GAYNOR, JJ , GUERRA, G , SAGESHIMA, J , ROTH, D , CHEN, LD , KUPIN, W , MATTIAZZI, A , TUEROS, L , FLORES, S , ET AL (2017) RANDOMIZED TRIAL OF RATG/DACLIZUMAB VS. RATG/ALEMTUZUMAB AS DUAL INDUCTION THERAPY IN RENAL TRANSPLANTATION: RESULTS AT 8 YEARS OF FOLLOW-UP.TRANSPLANT IMMUNOLOGY. VOL. 40. ISSUE . P. 42 -50 40 71% 0
10 CIANCIO, G , GAYNOR, JJ , GUERRA, G , SAGESHIMA, J , CHEN, L , MATTIAZZI, A , ROTH, D , KUPIN, W , TUEROS, L , FLORES, S , ET AL (2014) RANDOMIZED TRIAL OF THREE INDUCTION ANTIBODIES IN KIDNEY TRANSPLANTATION: LONG-TERM RESULTS.TRANSPLANTATION. VOL. 97. ISSUE 11. P. 1128-1138 39 70% 10

Classes with closest relation at Level 1



Rank Class id link
1 10800 OKT3//MUROMONAB CD3//ANTI OKT3 ANTIBODIES
2 7788 TRANSPLANTATION PROCEEDINGS//STEROID WITHDRAWAL//CORTICOSTEROID WITHDRAWAL
3 8383 LIVER TRANSPLANTATION//TRANSPLANTATION//CALCINEURIN INHIBITORS
4 16475 HEART TRANSPLANTATION//DUAL ORGAN TRANSPLANTATION//HEART KIDNEY TRANSPLANTATION
5 3597 SIROLIMUS//EVEROLIMUS//BELATACEPT
6 22211 IMMUKNOW//IMMUNE MONITORING//PHARMACODYNAMIC MONITORING
7 22413 ALEMTUZUMAB//DACLIZUMAB//MS CLIN CENT TEXAS
8 5092 PROTOCOL BIOPSY//SUBCLINICAL REJECTION//CHRONIC ALLOGRAFT NEPHROPATHY
9 5296 TRANSPLANTAT BIOL//MIXED CHIMERISM//EMORY TRANSPLANT
10 3388 EXPANDED CRITERIA DONORS//DELAYED GRAFT FUNCTION//GRAFT SURVIVAL

Go to start page